FIGURE 6.
Antibacterial efficacy of PLCL scaffolds incorporated with 0.0 (“0”), 0.1 (“1×”), 0.5 (“5×”), and 1.0 (“10×”) mg(Ag) g(scaffold)−1. (a) Staphylococcus aureus (ATCC 25213), (b) Escherichia coli (MG1655).
Antibacterial efficacy of PLCL scaffolds incorporated with 0.0 (“0”), 0.1 (“1×”), 0.5 (“5×”), and 1.0 (“10×”) mg(Ag) g(scaffold)−1. (a) Staphylococcus aureus (ATCC 25213), (b) Escherichia coli (MG1655).